(21 days)
Not Found
Not Found
No
The summary describes a centrifuge system for preparing blood components and bone marrow concentrate. There is no mention of AI, ML, image processing, or any other technology typically associated with AI/ML in medical devices. The description focuses on a physical process (centrifugation) rather than data analysis or interpretation.
No.
The device is used to prepare blood components (platelet poor plasma, platelet concentrate) or cell concentrate from bone marrow, which are then used in a clinical setting; it does not directly treat a medical condition.
No
Explanation: The device is intended for the preparation of blood components (platelet poor plasma, platelet concentrate, and cell concentrate from bone marrow), not for diagnosing a disease or condition. It is a sample preparation device, not a diagnostic one.
No
The device description explicitly states "Centrifuge System," which is a piece of hardware used for separating components of a liquid. The intended use also describes the preparation of blood and bone marrow samples, which requires physical manipulation of these samples, indicating a hardware component.
Based on the provided information, the SmartPReP2 Centrifuge System and the SmartPReP Centrifuge System are not IVDs (In Vitro Diagnostics).
Here's why:
- IVDs are used to examine specimens from the human body to provide information for diagnosis, monitoring, or screening. The intended use of these centrifuges is to prepare components from blood and bone marrow samples. They are a tool used in the process of preparing samples, not for directly analyzing the samples to provide diagnostic information.
- The description focuses on the preparation of samples (platelet poor plasma, platelet concentrate, cell concentrate). It doesn't mention any analysis, measurement, or diagnostic interpretation of these prepared components.
Therefore, these devices are considered laboratory or point-of-care equipment used in the preparation of biological samples, rather than IVDs.
N/A
Intended Use / Indications for Use
SmartPReP®2 Centrifuge System with ACD-A (30ml): The SmartPReP2 Centrifuge System is intended to be used in the clinical laboratory or intraoperatively at point-of-care for the safe and rapid preparation of platelet poor plasma and platelet concentrate from a small sample of blood and for preparation of a cell concentrate from bone marrow.
SmartPRePTM Centrifuge System with ACD-A (30ml): The SmartPReP Centrifuge System is designed to be used in the clinical laboratory or intraoperatively at point-of-care for the safe and rapid preparation of platelet poor plasma and platelet concentrate from a small sample of blood.
Product codes
FMF, JQC
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
clinical laboratory or intraoperatively at point-of-care
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.2050 General purpose laboratory equipment labeled or promoted for a specific medical use.
(a)
Identification. General purpose laboratory equipment labeled or promoted for a specific medical use is a device that is intended to prepare or examine specimens from the human body and that is labeled or promoted for a specific medical use.(b)
Classification. Class I (general controls). The device is identified in paragraph (a) of this section and is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of a human figure in profile, with three faces overlapping to represent the department's focus on people and well-being. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the figure.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
January 13, 2016
Harvest Technologies Corp. Mr. John D. Bonasera Director, Regulatory Affairs 40 Grissom Road Suite 100 Plymouth, MA 02360
Re: K103340
Trade/Device Name: SmartPReP2 Centrifuge System with ACD-A (30ml) and SmartPReP Centrifuge System with ACD-A (30ml) Regulation Number: 21 CFR 880.5860 Regulation Name: Piston syringe Regulatory Class: Class II Product Code: FMF, JQC Dated: November 9, 2010 Received: November 15, 2010
Dear Mr. Bonasera:
This letter corrects our substantially equivalent letter of December 6, 2010.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Leonthena R. Carrington -S
Leonthena R. Carrington, MS, MBA, MT(ASCP) Director Division of Immunology and Hematology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
INDICATIONS FOR USE FORM
510k Number (if known)
Device Name: SmartPReP®2 Centrifuge System with ACD-A (30ml)
Indications for Use: The SmartPReP2 Centrifuge System is intended to be used in the clinical laboratory or intraoperatively at point-of-care for the safe and rapid preparation of platelet poor plasma and platelet concentrate from a small sample of blood and for preparation of a cell concentrate from bone marrow.
Prescription Use Part 21 CFR 801 Subpart D
and
Over-The-Counter Use 21 CFR 810 Subpart C
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ----------------------------------------------------------------------------------
Division Sign-Off
Office of In Vitro Diagnostic Office of in Millo Blagher Device Evaluation and Safety
510(k) K103340
3
INDICATIONS FOR USE FORM
510k Number (if known)
Device Name: SmartPRePTM Centrifuge System with ACD-A (30ml)
Indications for Use: The SmartPReP Centrifuge System is designed to be used in the clinical laboratory or intraoperatively at point-of-care for the safe and rapid preparation of platelet poor plasma and platelet concentrate from a small sample of blood.
Prescription Use ﺮ ﺍﻟﻤﺮﺍﺟﻊ ﺍﻟﻤﺮﺍﺟﻊ Part 21 CFR 801 Subpart D
and
Over-The-Counter Use 21 CFR 810 Subpart C
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) ******************************************************************************************************************************************************************************
Division Sign-Off
Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K103340